Search results
Results from the WOW.Com Content Network
An example of application of pseudonymization procedure is creation of datasets for de-identification research by replacing identifying words with words from the same category (e.g. replacing a name with a random name from the names dictionary), [11] [12] [13] however, in this case it is in general not possible to track data back to its origins.
This list contains acronyms, initialisms, and pseudo-blends that begin with the letter D. For the purposes of this list: acronym = an abbreviation pronounced as if it were a word, e.g., SARS = severe acute respiratory syndrome, pronounced to rhyme with cars; initialism = an abbreviation pronounced wholly or partly using the names of its ...
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes). This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
D/T: due to DTA: descending thoracic aorta: DTaP: diphtheria–tetanus–acellular pertussis (combined vaccination) DTP: diphtheria-tetanus-pertussis (combined vaccination) DTR: deep tendon reflex: DTs: delirium tremens: DU: duodenal ulcer (see peptic ulcer) DUB: dysfunctional uterine bleeding: DVT: deep vein thrombosis: D/W: discussed with DW ...
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. ...
This page was last edited on 11 December 2024, at 07:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Eponymous surgical procedures are generally named after the surgeon or surgeons who performed or reported them first. In some instances they are named after the surgeon who popularised them or refined existing procedures, and occasionally are named after the patient who first underwent the procedure.
[18]: 10 It was consolidated with their pharmacy benefit management company, PharmaCare in 2002. In their 2001 annual report CVS anticipated that the "$16 billion specialty pharmacy market" would grow at "an even faster rate than traditional pharmacy due in large part to the robust pipeline of biotechnology drugs."